CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer. (2020)
Attributed to:
Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ctro.2020.09.006
PubMed Identifier: 33072895
Publication URI: http://europepmc.org/abstract/MED/33072895
Type: Journal Article/Review
Volume: 25
Parent Publication: Clinical and translational radiation oncology
ISSN: 2405-6308